Sodium Sulfite vs Blue Dye 1: which is worse?

What is Sodium Sulfite?

Sodium sulfite is an inorganic sulfite salt used as a food preservative and antioxidant. It releases sulfur dioxide when it contacts water or acid, which acts as the active antimicrobial and antioxidant agent. Part of the broader sulfite family of food additives (including sulfur dioxide E220, sodium bisulfite E222, and others).

What is Blue Dye 1?

Blue Dye 1 (Brilliant Blue FCF) is a synthetic blue triarylmethane dye derived from petroleum. It produces a brilliant sky-blue color and is highly water-soluble. Unlike the azo dyes (Red 40, Yellow 5/6), Blue 1 belongs to the triarylmethane chemical class.

Documented risks

Sodium Sulfite: Sulfites are among the more significant food allergy/intolerance triggers. An estimated 1 in 100 people, and up to 5% of asthmatics, are sulfite-sensitive. Reactions can include urticaria, angioedema, bronchospasm, and in severe cases anaphylaxis. Sulfite-induced asthma can be severe; several deaths attributable to sulfite-triggered anaphylaxis have been documented. The FDA banned sulfites from fresh produce and restaurant salad bars in 1986 after several deaths and severe reactions were linked to sulfite-treated salads. FDA mandates that sulfite content above 10 ppm be declared on US food labels. All forms of sulfites (E220-E228) share these sensitization concerns.

Blue Dye 1: Blue Dye 1 was historically banned in several European countries before EU harmonization permitted it (as E133). EFSA's 2010 comprehensive safety re-evaluation found no evidence of carcinogenicity in standard animal tests. The ADI was set at 6 mg/kg body weight. The most significant documented safety concern for Blue 1 involves intravenous/enteral administration rather than dietary intake. In 2003, the FDA issued a Public Health Advisory warning against using Blue 1 (used as a food coloring agent in enteral nutrition formulas to detect aspiration in critically ill patients) after multiple case reports — including deaths — documented that Blue 1 can be absorbed through damaged intestinal mucosa and cause cardiovascular instability, metabolic acidosis, and death. The FDA advisory specifically warned against this clinical use in intensive care patients. This is a medical use concern, not a dietary intake concern. For healthy consumers eating normally, EFSA found no significant safety concerns at food use levels. Blue 1 was not included in the 2007 Lancet hyperactivity study. However, it falls under the FDA's April 2025 announcement to phase out all petroleum-based synthetic food dyes, reflecting updated policy on the class as a whole rather than specific Blue 1 data. Historically, Blue 1 was banned in multiple European countries due to safety concerns, though EU harmonization later permitted it with E-number labeling requirements. This history suggests precautionary concern even when formal regulatory action was not sustained.